Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Heartburn Topic Center

Featured Article

Quiz
Recommended Dosage of an H2 Blocker for Gastroesophageal Reflux Disease
11/18/2022
What is the recommended dosage of famotidine for patients with gastroesophageal reflux disease (GERD) who weigh at least 40 kg?
What is the recommended dosage of famotidine for patients with gastroesophageal reflux disease (GERD) who weigh at least 40 kg?
What is the recommended dosage...
11/18/2022
Pharmacy Learning Network
News
Vonoprazan vs Esomeprazole for Treating Symptomatic Gastroesophageal Reflux Disease
11/14/2022
Investigators compared the efficacy and safety of vonoprazan and esomeprazole in patients with gastroesophageal reflux disease who responded only partially to proton pump inhibitors.
Investigators compared the efficacy and safety of vonoprazan and esomeprazole in patients with gastroesophageal reflux disease who responded only partially to proton pump inhibitors.
Investigators compared the...
11/14/2022
Pharmacy Learning Network
Poll
Recommending Over-the-Counter Medications for Heartburn
10/25/2022
Of the following over-the-counter medications, which therapy are you most likely to recommend to patients with heartburn?
Of the following over-the-counter medications, which therapy are you most likely to recommend to patients with heartburn?
Of the following...
10/25/2022
Pharmacy Learning Network
News
Adding Dopamine Antagonist to PPI Therapy for GERD
10/18/2022
“Although PPIs are first-line medications for GERD, up to one-third of patients do not experience symptom relief after an 8-week course of PPI therapy," researchers said.
“Although PPIs are first-line medications for GERD, up to one-third of patients do not experience symptom relief after an 8-week course of PPI therapy," researchers said.
“Although PPIs are first-line...
10/18/2022
Pharmacy Learning Network
Quiz
Identifying Preferred H2 Blocker for Treating GERD in Breastfeeding Patients
09/26/2022
Which histamine H2-receptor antagonist is considered the preferred option for managing heartburn in patients who are lactating?
Which histamine H2-receptor antagonist is considered the preferred option for managing heartburn in patients who are lactating?
Which histamine H2-receptor...
09/26/2022
Pharmacy Learning Network
News
Vonoprazan vs PPIs for Treating Heartburn in Patients With Erosive Esophagitis
09/13/2022
In a systematic review and meta-analysis, researchers compared the efficacy of vonoprazan and proton pump inhibitors for resolving heartburn in patients with erosive esophagitis.
In a systematic review and meta-analysis, researchers compared the efficacy of vonoprazan and proton pump inhibitors for resolving heartburn in patients with erosive esophagitis.
In a systematic review and...
09/13/2022
Pharmacy Learning Network
News
Heartburn Center Successfully Centralizes Care in a Community Setting
12/22/2021
Integrating a comprehensive heartburn center in a community setting was commercially viable and boosted patient satisfaction, according to recent findings.
Integrating a comprehensive heartburn center in a community setting was commercially viable and boosted patient satisfaction, according to recent findings.
Integrating a comprehensive...
12/22/2021
Pharmacy Learning Network
Quiz
Understanding Overnight Symptoms of Heartburn
12/22/2021
How many US adults who have heartburn at least once a week report experiencing symptoms overnight?
How many US adults who have heartburn at least once a week report experiencing symptoms overnight?
How many US adults who have...
12/22/2021
Pharmacy Learning Network
Quiz
Preventing Symptoms of Heartburn
12/22/2021
True or False: Eating more food can help reduce heartburn symptoms.
True or False: Eating more food can help reduce heartburn symptoms.
True or False: Eating more food...
12/22/2021
Pharmacy Learning Network
News
Proton Pump Inhibitors May Reduce Severity of Gum Disease
11/08/2021
“Proton pump inhibitors (PPIs) are commonly prescribed for the management of acid-related gastrointestinal disorders,” researchers explained. “PPIs could potentially be used in combination with other periodontal treatments."
“Proton pump inhibitors (PPIs) are commonly prescribed for the management of acid-related gastrointestinal disorders,” researchers explained. “PPIs could potentially be used in combination with other periodontal treatments."
“Proton pump inhibitors (PPIs)...
11/08/2021
Pharmacy Learning Network
Quiz
Identifying Active Ingredients for Treating Heartburn
10/16/2021
What kind of active ingredient is famotidine?
What kind of active ingredient is famotidine?
What kind of active ingredient...
10/16/2021
Pharmacy Learning Network

Newsfeed

News
Vonoprazan vs Esomeprazole for Treating Symptomatic Gastroesophageal Reflux Disease
11/14/2022
Investigators compared the efficacy and safety of vonoprazan and esomeprazole in patients with gastroesophageal reflux disease who responded only partially to proton pump inhibitors.
Investigators compared the efficacy and safety of vonoprazan and esomeprazole in patients with gastroesophageal reflux disease who responded only partially to proton pump inhibitors.
Investigators compared the...
11/14/2022
Pharmacy Learning Network
News
Adding Dopamine Antagonist to PPI Therapy for GERD
10/18/2022
“Although PPIs are first-line medications for GERD, up to one-third of patients do not experience symptom relief after an 8-week course of PPI therapy," researchers said.
“Although PPIs are first-line medications for GERD, up to one-third of patients do not experience symptom relief after an 8-week course of PPI therapy," researchers said.
“Although PPIs are first-line...
10/18/2022
Pharmacy Learning Network
News
Vonoprazan vs PPIs for Treating Heartburn in Patients With Erosive Esophagitis
09/13/2022
In a systematic review and meta-analysis, researchers compared the efficacy of vonoprazan and proton pump inhibitors for resolving heartburn in patients with erosive esophagitis.
In a systematic review and meta-analysis, researchers compared the efficacy of vonoprazan and proton pump inhibitors for resolving heartburn in patients with erosive esophagitis.
In a systematic review and...
09/13/2022
Pharmacy Learning Network
News
Heartburn Center Successfully Centralizes Care in a Community Setting
12/22/2021
Integrating a comprehensive heartburn center in a community setting was commercially viable and boosted patient satisfaction, according to recent findings.
Integrating a comprehensive heartburn center in a community setting was commercially viable and boosted patient satisfaction, according to recent findings.
Integrating a comprehensive...
12/22/2021
Pharmacy Learning Network
News
Proton Pump Inhibitors May Reduce Severity of Gum Disease
11/08/2021
“Proton pump inhibitors (PPIs) are commonly prescribed for the management of acid-related gastrointestinal disorders,” researchers explained. “PPIs could potentially be used in combination with other periodontal treatments."
“Proton pump inhibitors (PPIs) are commonly prescribed for the management of acid-related gastrointestinal disorders,” researchers explained. “PPIs could potentially be used in combination with other periodontal treatments."
“Proton pump inhibitors (PPIs)...
11/08/2021
Pharmacy Learning Network
News
Research Identifies OTC Meds Commonly Involved in Drug-Drug Interactions
10/08/2021
“The most significant finding,” Dr Oliver wrote, “was the lack of high-quality evidence for commonly acknowledged interactions. High-quality interaction studies involving different phenotypes in drug metabolism (cytochrome P450) and...
“The most significant finding,” Dr Oliver wrote, “was the lack of high-quality evidence for commonly acknowledged interactions. High-quality interaction studies involving different phenotypes in drug metabolism (cytochrome P450) and...
“The most significant finding,”...
10/08/2021
Pharmacy Learning Network
News
Pharmacist Intervention Improved PPI Use Among Patients With Heartburn, Other Acid-related Disorders
09/23/2021
“In a busy inpatient setting, we developed a feasible way to assess PPI therapy, deimplement nonguideline-concordant PPI use, and provide follow-up to assess any unintended consequences,” explained researchers.
“In a busy inpatient setting, we developed a feasible way to assess PPI therapy, deimplement nonguideline-concordant PPI use, and provide follow-up to assess any unintended consequences,” explained researchers.
“In a busy inpatient setting, we...
09/23/2021
Pharmacy Learning Network
News
Prescription-Strength Heartburn Drug Recalled
11/13/2020
A Class II recall is active for a prescription proton-pump inhibitor that treats stomach ulcers, gastroesophageal reflux disease, and high levels of stomach acid.
A Class II recall is active for a prescription proton-pump inhibitor that treats stomach ulcers, gastroesophageal reflux disease, and high levels of stomach acid.
A Class II recall is active for...
11/13/2020
Pharmacy Learning Network
News
OTC Heartburn Medication Recalled
12/13/2019
Sanofi-Aventis US issued a precautionary, voluntarily recall of all over-the-counter Zantac (ranitidine) products because of possible contamination with NDMA.
Sanofi-Aventis US issued a precautionary, voluntarily recall of all over-the-counter Zantac (ranitidine) products because of possible contamination with NDMA.
Sanofi-Aventis US issued a...
12/13/2019
Pharmacy Learning Network
News
Heartburn Drug Recalled
11/08/2019
The FDA is recalling nearly 70,000 bottles of an antacid and antihistamine used to treat heartburn, stomach ulcers, and gastroesophageal reflux disease.
The FDA is recalling nearly 70,000 bottles of an antacid and antihistamine used to treat heartburn, stomach ulcers, and gastroesophageal reflux disease.
The FDA is recalling nearly...
11/08/2019
Pharmacy Learning Network
News
Antidepressant Recalled for Impurity
10/23/2024
Breckenridge Pharmaceutical Inc. is recalling 7107 bottles of duloxetine delayed-release capsules because of an N-nitroso duloxetine impurity.
Breckenridge Pharmaceutical Inc. is recalling 7107 bottles of duloxetine delayed-release capsules because of an N-nitroso duloxetine impurity.
Breckenridge Pharmaceutical Inc....
10/23/2024
Pharmacy Learning Network
News
Chemotherapy Drug Recalled
10/23/2024
Accord Healthcare Inc. is recalling vials of cisplatin injection after samples failed to meet impurity/degradation specifications during testing.
Accord Healthcare Inc. is recalling vials of cisplatin injection after samples failed to meet impurity/degradation specifications during testing.
Accord Healthcare Inc. is...
10/23/2024
Pharmacy Learning Network
News
Contaminated Antimicrobial Under Class I Recall
10/23/2024
Nearly 2000 bottles of atovaquone oral suspension distributed by Bionpharma Inc. are under a Class I recall for contamination with Cohnella bacteria.
Nearly 2000 bottles of atovaquone oral suspension distributed by Bionpharma Inc. are under a Class I recall for contamination with Cohnella bacteria.
Nearly 2000 bottles of...
10/23/2024
Pharmacy Learning Network
News
Study Sheds Light on RSV Structural Protein Organization, Paving the Way for Vaccine Improvements
10/18/2024
A new study published in Nature Communications has provided crucial insights into the structure and organization of respiratory syncytial virus (RSV).
A new study published in Nature Communications has provided crucial insights into the structure and organization of respiratory syncytial virus (RSV).
A new study published in Nature...
10/18/2024
Pharmacy Learning Network
News
Supplements Under Class I Recall
10/16/2024
All lots of Vail-Bon Jie Yang Wan capsules from 123Herbals are under a Class I recall for being tainted with the undeclared dexamethasone and chlorpheniramine.
All lots of Vail-Bon Jie Yang Wan capsules from 123Herbals are under a Class I recall for being tainted with the undeclared dexamethasone and chlorpheniramine.
All lots of Vail-Bon Jie Yang...
10/16/2024
Pharmacy Learning Network
News
Defective Nasal Spray Recalled
10/10/2024
Glenmark Pharmaceuticals Inc. USA is recalling Ryaltris nasal spray because of a defective delivery system.
Glenmark Pharmaceuticals Inc. USA is recalling Ryaltris nasal spray because of a defective delivery system.
Glenmark Pharmaceuticals Inc....
10/10/2024
Pharmacy Learning Network
News
Statin Recalled for Containing Anticonvulsant
10/10/2024
Nivagen Pharmaceuticals Inc. is recalling atorvastatin calcium tablets after a 400-mg carbamazepine extended-release tablet was found in a bottle.
Nivagen Pharmaceuticals Inc. is recalling atorvastatin calcium tablets after a 400-mg carbamazepine extended-release tablet was found in a bottle.
Nivagen Pharmaceuticals Inc. is...
10/10/2024
Pharmacy Learning Network
News
Class I Recall for COVID-19 Treatment
10/10/2024
Vials of Veklury (remdesivir) for injection are under a Class I recall after a customer found a glass particle in a vial.
Vials of Veklury (remdesivir) for injection are under a Class I recall after a customer found a glass particle in a vial.
Vials of Veklury (remdesivir)...
10/10/2024
Pharmacy Learning Network
News
RSV Identified as Significant Contributor to COPD Exacerbations
10/04/2024
Respiratory syncytial virus (RSV) is linked to approximately 8.7% of chronic obstructive pulmonary disease (COPD) exacerbations in European cohorts, with RSV-related exacerbations showing a tendency to resolve more quickly than those caused...
Respiratory syncytial virus (RSV) is linked to approximately 8.7% of chronic obstructive pulmonary disease (COPD) exacerbations in European cohorts, with RSV-related exacerbations showing a tendency to resolve more quickly than those caused...
Respiratory syncytial virus...
10/04/2024
Pharmacy Learning Network
News
OTC Dry Eye Ointments Recalled for Sterility Concerns
10/02/2024
AbbVie Inc. is recalling more than 3 million tubes of Refresh PM and Refresh Lacri-Lube lubricant eye ointment due to a lack of assurance of sterility.
AbbVie Inc. is recalling more than 3 million tubes of Refresh PM and Refresh Lacri-Lube lubricant eye ointment due to a lack of assurance of sterility.
AbbVie Inc. is recalling more...
10/02/2024
Pharmacy Learning Network

Quiz Series

Quiz
Recommended Dosage of an H2 Blocker for Gastroesophageal Reflux Disease
11/18/2022
What is the recommended dosage of famotidine for patients with gastroesophageal reflux disease (GERD) who weigh at least 40 kg?
What is the recommended dosage of famotidine for patients with gastroesophageal reflux disease (GERD) who weigh at least 40 kg?
What is the recommended dosage...
11/18/2022
Pharmacy Learning Network
Quiz
Identifying Preferred H2 Blocker for Treating GERD in Breastfeeding Patients
09/26/2022
Which histamine H2-receptor antagonist is considered the preferred option for managing heartburn in patients who are lactating?
Which histamine H2-receptor antagonist is considered the preferred option for managing heartburn in patients who are lactating?
Which histamine H2-receptor...
09/26/2022
Pharmacy Learning Network
Quiz
Understanding Overnight Symptoms of Heartburn
12/22/2021
How many US adults who have heartburn at least once a week report experiencing symptoms overnight?
How many US adults who have heartburn at least once a week report experiencing symptoms overnight?
How many US adults who have...
12/22/2021
Pharmacy Learning Network
Quiz
Preventing Symptoms of Heartburn
12/22/2021
True or False: Eating more food can help reduce heartburn symptoms.
True or False: Eating more food can help reduce heartburn symptoms.
True or False: Eating more food...
12/22/2021
Pharmacy Learning Network
Quiz
Identifying Active Ingredients for Treating Heartburn
10/16/2021
What kind of active ingredient is famotidine?
What kind of active ingredient is famotidine?
What kind of active ingredient...
10/16/2021
Pharmacy Learning Network
Quiz
Overnight Remedies for Heartburn
10/16/2021
True or False: Antacids and H2 blockers both provide stomach acid control through the night.
True or False: Antacids and H2 blockers both provide stomach acid control through the night.
True or False: Antacids and H2...
10/16/2021
Pharmacy Learning Network
Quiz
How to Relieve Heartburn
10/07/2021
Can you identify remedies for heartburn from the following list?
Can you identify remedies for heartburn from the following list?
Can you identify remedies for...
10/07/2021
Pharmacy Learning Network
Quiz
Discerning Causes of Heartburn
10/07/2021
True or False: Increased pressure on your abdomen from pregnancy can trigger symptoms of heartburn.
True or False: Increased pressure on your abdomen from pregnancy can trigger symptoms of heartburn.
True or False: Increased...
10/07/2021
Pharmacy Learning Network
Quiz
Identifying Heartburn Myths
10/07/2021
Which of the following does not help to alleviate heartburn?
Which of the following does not help to alleviate heartburn?
Which of the following does not...
10/07/2021
Pharmacy Learning Network
Quiz
Distinguishing Between Active Ingredients in Heartburn Treatments
09/09/2021
True or False: The active ingredient in an H2 blocker is esomeprazole/omeprazole.
True or False: The active ingredient in an H2 blocker is esomeprazole/omeprazole.
True or False: The active...
09/09/2021
Pharmacy Learning Network
Quiz
Comorbidity Risk of Alzheimer Disease and MS
10/22/2024
True or False: Among patients with MS, amyloid plaque accumulation in the brain was more likely in those with a typical MS history.
True or False: Among patients with MS, amyloid plaque accumulation in the brain was more likely in those with a typical MS history.
True or False: Among patients...
10/22/2024
Pharmacy Learning Network
Quiz
FDA Approval for Alzheimer Disease Treatments
10/21/2024
True or False: Lecanemab-IRMB (Leqembi™) is the second Alzheimer drug that has affected the course of the disease successfully in phase 3, had a low side effect profile and then got full FDA approval.
True or False: Lecanemab-IRMB (Leqembi™) is the second Alzheimer drug that has affected the course of the disease successfully in phase 3, had a low side effect profile and then got full FDA approval.
True or False: Lecanemab-IRMB...
10/21/2024
Pharmacy Learning Network
Quiz
Understanding the Link Between Multiple Sclerosis and Alzheimer Disease
10/03/2024
True or False: Patients with a typical multiple sclerosis (MS) history are more likely to accumulate amyloid plaques in the brain compared to those with atypical presentations.
True or False: Patients with a typical multiple sclerosis (MS) history are more likely to accumulate amyloid plaques in the brain compared to those with atypical presentations.
True or False: Patients with a...
10/03/2024
Pharmacy Learning Network
Quiz
Differences in Alzheimer Disease Treatment Options
09/26/2024
Which significant difference between donanemab and lecanemab was mentioned in the Phase III TRAILBLAZER-ALZ 2 study?
Which significant difference between donanemab and lecanemab was mentioned in the Phase III TRAILBLAZER-ALZ 2 study?
Which significant difference...
09/26/2024
Pharmacy Learning Network
Quiz
Alzheimer Disease Treatment Terminology
09/26/2024
What does ARIA-E stand for in Alzheimer disease treatment?
What does ARIA-E stand for in Alzheimer disease treatment?
What does ARIA-E stand for in...
09/26/2024
Pharmacy Learning Network
Quiz
Hemorrhaging Incidents in Alzheimer Disease Treatment
09/20/2024
True or False: A potential side effect noted in treating Alzheimer disease with lecanemab-IRMB is amyloid-related imaging abnormality type H (ARIA-H).
True or False: A potential side effect noted in treating Alzheimer disease with lecanemab-IRMB is amyloid-related imaging abnormality type H (ARIA-H).
True or False: A potential side...
09/20/2024
Pharmacy Learning Network
Quiz
Post-Treatment Alzheimer Disease Progression
09/18/2024
True or False: Amyloid plaque levels begin to rise again within 1 year of donanemab treatment.
True or False: Amyloid plaque levels begin to rise again within 1 year of donanemab treatment.
True or False: Amyloid plaque...
09/18/2024
Pharmacy Learning Network
Quiz
Anti-Amyloid Drugs for Treating Alzheimer Disease
09/12/2024
Quiz: According to findings from the Phase III TRAILBLAZER-ALZ 2 study, upon which the FDA approval of donanemab is based, what percentage of patients were able to discontinue the drug within a year?
Quiz: According to findings from the Phase III TRAILBLAZER-ALZ 2 study, upon which the FDA approval of donanemab is based, what percentage of patients were able to discontinue the drug within a year?
Quiz: According to findings from...
09/12/2024
Pharmacy Learning Network
Quiz
Alzheimer Disease Treatment Breakthroughs
08/27/2024
True or False: Lecanemab is the first Alzheimer's drug to successfully affect the course of the disease in phase 3 trials and receive full FDA approval.
True or False: Lecanemab is the first Alzheimer's drug to successfully affect the course of the disease in phase 3 trials and receive full FDA approval.
True or False: Lecanemab is the...
08/27/2024
Pharmacy Learning Network
Quiz
Adverse Infusion Reactions During Alzheimer Disease Treatment
08/20/2024
True or False: Some patients treated with Lecanemab may experience an adverse infusion reaction.
True or False: Some patients treated with Lecanemab may experience an adverse infusion reaction.
True or False: Some patients...
08/20/2024
Pharmacy Learning Network

Advertisement

Sign Up Today! Enter your email below.

Pharmacy Learning Network Newsletter

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement